|
HSPA4L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.600300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.238200E-03 |
| Normal-vs-Stage2 |
7.262600E-01 |
| Normal-vs-Stage3 |
1.358180E-01 |
| Normal-vs-Stage4 |
9.393400E-01 |
| Stage1-vs-Stage2 |
7.962000E-02 |
| Stage1-vs-Stage3 |
4.280600E-01 |
| Stage1-vs-Stage4 |
9.437800E-02 |
| Stage2-vs-Stage3 |
4.003800E-01 |
| Stage2-vs-Stage4 |
7.842200E-01 |
| Stage3-vs-Stage4 |
3.485000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.045560E-02 |
| Normal-vs-AfricanAmerican |
3.555700E-02 |
| Normal-vs-Asian |
9.654400E-01 |
| Caucasian-vs-AfricanAmerican |
9.354000E-01 |
| Caucasian-vs-Asian |
3.125000E-01 |
| AfricanAmerican-vs-Asian |
3.045200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.424400E-03 |
| Normal-vs-Female |
5.393800E-01 |
| Male-vs-Female |
1.289880E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.929600E-02 |
| Normal-vs-Extreme_Weight |
5.956700E-03 |
| Normal-vs-Obese |
3.774100E-02 |
| Normal-vs-Extreme_Obese |
4.933800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.887400E-01 |
| Normal_Weight-vs-Obese |
8.795000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.241600E-01 |
| Extreme_Weight-vs-Obese |
3.179200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.694000E-01 |
| Obese-vs-Extreme_Obese |
5.108400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.570400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.748400E-02 |
| Normal-vs-Age(61-80Yrs) |
9.476500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.891890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.913800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.177800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.434600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.783800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.634000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.554000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.760800E-03 |
| Normal-VS-Type2 PRCC |
1.612620E-01 |
| Normal-VS-KIRP CIMP |
4.930000E-01 |
| Normal-VS-Unclassified PRCC |
5.403800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.922200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.175400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.216000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.582300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.275200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.857600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.571800E-02 |
| Normal-vs-N1 |
3.238600E-01 |
| Normal-vs-N2 |
9.652600E-01 |
| N0-vs-N1 |
3.525400E-01 |
| N0-vs-N2 |
6.561800E-01 |
| N1-vs-N2 |
8.055000E-01 |
|
|
